Literature DB >> 6978887

Immunoreactive human epidermal growth factor in human pancreatic juice.

Y Hirata, M Uchihashi, M Nakajima, T Fujita, S Matsukura.   

Abstract

Human epidermal growth factor (hEGF), which stimulates the growth of a variety of cells in culture, has recently been isolated from human urine. In the present study, we identified significant amounts of immunoreactive (IR) hEGF (mean +/- SE, 2.3 +/- 0.09 ng/ml; n = 3) in human pancreatic juice. The IR-hEGF materials were immunologically indistinguishable from standard hEGF, although they were only 5% as active in receptor binding to human placental membrane as in RIA. Gel exclusion chromatography of the pancreatic juice under neutral and acidic conditions revealed three distinct IR-hEGF components with different molecular sizes. Incubation of 125I-labeled hEGF with either the pancreatic juice or the high molecular weight component(s) yielded no aggregation or degradation products. These data suggest that fully immunoreactive but much less bioactive hEGF-like substances which are heterogeneous in size are secreted into human pancreatic juice. Their tissue(s) of origin and physiological functions, if any, remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6978887     DOI: 10.1210/jcem-54-6-1242

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Two subclasses of EGF receptors in the human pancreatic cancer cell lines CAPAN-1 and MIA PaCa-2.

Authors:  P Oustry; A Estival; L Pradayrol; N Vaysse; F Clémente
Journal:  Int J Pancreatol       Date:  1990-03

Review 2.  Adult pancreatic alpha-cells: a new source of cells for beta-cell regeneration.

Authors:  Cheng-Ho Chung; Fred Levine
Journal:  Rev Diabet Stud       Date:  2010-08-10

3.  Release and binding of epidermal growth factor in the pancreas of rats.

Authors:  J Jaworek; S J Konturek; W Bielanski; J Bilski; M Hladij
Journal:  Int J Pancreatol       Date:  1992-02

Review 4.  Exocrine secretion of pancreatic hormones: possible mechanisms.

Authors:  P M Pour; R E Hauser
Journal:  Int J Pancreatol       Date:  1987-08

5.  Alterations in EGF binding to acini during pancreatic regeneration in the rat.

Authors:  J S Brockenbrough; G C Weir; M Korc
Journal:  Int J Pancreatol       Date:  1988-12

6.  Distribution, release, and secretory activity of epidermal growth factor in the pancreas.

Authors:  J Jaworek; S J Konturek
Journal:  Int J Pancreatol       Date:  1990-04

7.  Distribution of epidermal growth factor in rat ocular and periocular tissues.

Authors:  H Watanabe; Y Ohashi; S Kinoshita; R Manabe; K Ohshiden
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-04       Impact factor: 3.117

8.  Expression of epidermal growth factor and its mRNA in pig kidney, pancreas and other tissues.

Authors:  T J Vaughan; J C Pascall; P S James; K D Brown
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

9.  Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.

Authors:  M Korc; B Chandrasekar; Y Yamanaka; H Friess; M Buchier; H G Beger
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.